Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Ioniqa Technologies B V is managing 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution indicates that each of the 2 pending office actions is being reviewed by a different examiner in a different technical division. With 2 distinct examiners and 2 distinct art units involved, the company must manage two separate prosecution tracks simultaneously.
RHOADES, DEREK JAMES is the busiest examiner for the portfolio, currently handling 1 busiest examiner pending office action. This 1 busiest examiner pending case represents half of the company's total of 2 pending office actions. Practitioners should note that the 2 distinct art units suggest different technical focuses within the biotechnology sector. Successfully resolving the 2 pending office actions will require addressing the specific concerns of both 2 distinct examiners across their respective 2 distinct art units. The 1 busiest examiner pending matter requires a tailored response to satisfy RHOADES, DEREK JAMES. Coordination between the 2 distinct art units is necessary to ensure consistent results for the 2 pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RHOADES, DEREK JAMES | 1 | 72.3% | +16.5% |
| RIETH, STEPHEN EDWARD | 1 | 45.5% | +33.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18021060 | Depolymerization Method Of A Waste Polymer Material and System Therefore | RIETH, STEPHEN EDWARD | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18021060 | Depolymerization Method Of A Waste Polymer Material and System Therefore | RIETH, STEPHEN EDWARD | 15d |
| 18572353 | Method and Reactor System for Depolymerizing a Terephthalate-Polymer Into Reusable Raw Material | RHOADES, DEREK JAMES | — |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| 1759 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18572353 | Method and Reactor System for Depolymerizing a Terephthalate-Polymer Into Reusable Raw Material | RHOADES, DEREK JAMES | 1692 | §102§103§112DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18021060 | Depolymerization Method Of A Waste Polymer Material and System Therefore | RIETH, STEPHEN EDWARD | 1759 | §103§112 | Final Rejection | 15d | Pending | Feb 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIoniqa Technologies B V has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Derek James Rhoades has the most, with 1 of Ioniqa Technologies B V's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
